Patents Assigned to Salk Institute Biotechnology/Industrial Associates, Inc.
-
Patent number: 5665579Abstract: Transgenic plants that are modified to produce fruits that have altered levels of soluble solids compared to non-transgenic species of the same species are provided. The transgenic plants are modified by introduction of DNA constructs that encode invertase operatively linked to DNA encoding regulatory regions that direct transcription of the DNA encoding invertase and to DNA encoding sequences that direct proper processing of the invertase through the secretory pathways of the plant and targeting of the invertase to the vacuole.In particular, DNA constructs encoding tomato plant vacuolar invertase in operative linkage with a developmentally regulated promoter region are provided. Preferred regulatory and structural DNA is obtained from genomic DNA clones and cDNA clones encoding tomato fruit vacuolar invertases from the commercial tomato plant, Lycopersicon esculentum, and wild tomato plant, Lycopersicon pimpinellifolium.Type: GrantFiled: May 17, 1994Date of Patent: September 9, 1997Assignee: The Salk Institute Biotechnology/Industrial Associates, Inc.Inventors: Leona C. Fitzmaurice, T. Erik Mirkov, Kathryn J. Elliott, William Owen Butler, Yoshihiro Konno, Craig Duane Dickinson
-
Patent number: 5576428Abstract: Transgenic plants that are modified to produce fruits that have altered levels of soluble solids compared to non-transgenic plants of the same species are provided. The transgenic plants are prepared by introducing into plants DNA constructs that encode invertase operatively linked to DNA encoding regulatory regions that direct transcription of the DNA encoding invertase and operatively linked to DNA encoding amino acids that direct proper processing of the invertase through the secretory pathways of the plant and targeting of the invertase to the vacuole.In particular, DNA constructs encoding tomato plant vacuolar invertase in operative linkage with a developmentally regulated promoter region are provided. Preferred regulatory and structural DNA is obtained from genomic DNA clones and cDNA clones encoding tomato fruit vacuolar invertases from the commercial tomato plant, Lycopersicon esculentum, and wild tomato plant, Lycopersicon pimpinellifolium.Type: GrantFiled: August 20, 1993Date of Patent: November 19, 1996Assignee: The Salk Institute Biotechnology/Industrial Associates, Inc.Inventors: William O. Butler, Yoshihiro Konno, Craig D. Dickinson, Leona C. Fitzmaurice, Theodore E. Mirkov, Kathryn J. Elliott
-
Patent number: 5407820Abstract: Calcium channel .alpha..sub.1 -subunit and .alpha..sub.2 -subunit-encoding cDNAs, and related compositions and methods, are provided.Type: GrantFiled: July 13, 1992Date of Patent: April 18, 1995Assignee: The Salk Institute Biotechnology/Industrial Associates, Inc.Inventors: Steven B. Ellis, Mark E. Williams, Michael M. Harpold, Arnold Schwartz, Robert Brenner
-
Patent number: 5401629Abstract: Recombinant cells are provided which are useful for assaying compounds for their agonist or antagonist activity with respect to ion channels and/or cell surface-localized receptors. In addition, assay methods employing the invention recombinant cells are provided.Type: GrantFiled: August 7, 1990Date of Patent: March 28, 1995Assignee: The Salk Institute Biotechnology/Industrial Associates, Inc.Inventors: Michael M. Harpold, Paul Brust
-
Patent number: 5369028Abstract: Human neuronal nicotinic acetylcholine receptor subunits are described, as are methods for producing cells containing functional receptors employing such subunits. Also described are assay methods for determining the presence of functional HnAChRs in transfected cells, and for determining the agonist or antagonist activity of compounds with respect to such cells.Type: GrantFiled: April 3, 1990Date of Patent: November 29, 1994Assignee: The Salk Institute Biotechnology/Industrial Associates, Inc.Inventors: Michael M. Harpold, Steven B. Ellis
-
Patent number: 5258302Abstract: Biologically active aprotinin (APR) molecules, naturally occurring, relatively short, single chain polypeptides, are prepared by growing methylotrophic yeast transformants containing in their genome at least one copy of a DNA sequence operably encoding APR, in operational association with a DNA sequence encoding the S. cerevisiae alpha mating factor pre-pro sequence (including a processing sequence selected from lys-arg-(glu-ala).sub.x, wherein x is an integer falling in the range of 0-3), both under the regulation of a promoter region of a gene of a methylotrophic yeast, under conditions allowing expression of said DNA sequences, and secretion of APR molecules into the culture medium.Also disclosed are novel DNA fragments and novel recombinant yeast strains which are useful in the practice of the present invention.Type: GrantFiled: July 30, 1990Date of Patent: November 2, 1993Assignee: The Salk Institute Biotechnology/Industrial Associates, Inc.Inventors: Thomas S. Vedvick, Michael E. Engel, Mary S. Urcan, Richard G. Buckholz, Jennifer A. Kinney
-
Patent number: 5231178Abstract: Method for the recovery and purification of intact, correctly-folded, monomeric insulin-like growth factor-1 peptide from large volumes of IGF-1-containing medium are described, comprising a series of adsorption-desorption steps employing a combination of cation exchange and hydrophobic interaction adsorbents. Product IGF-1 peptide is highly purified and suitable for use in a variety of clinical applications.Type: GrantFiled: October 28, 1991Date of Patent: July 27, 1993Assignee: The Salk Institute Biotechnology/Industrial Associates, Inc.Inventors: Gregory C. Holtz, Russell A. Brierley
-
Patent number: 5102789Abstract: Epidermal Growth Factor (EGF) is produced by recombinant DNA technology in Pichia pastoris yeast cells.Type: GrantFiled: March 15, 1989Date of Patent: April 7, 1992Assignee: The Salk Institute Biotechnology/Industrial Associates, Inc.Inventors: Robert S. Siegel, Richard G. Buckholz, Gregory P. Thill, Lillian M. Wondrack
-
Patent number: 5055393Abstract: Compositions and methods are provided for determining the sex of Bovine embryos and fetuses employing male-specific oligonucleotides in nucleic acid probe hybridization assay methods to assay the genomic DNA of embryonic or fetal cells for the presence of male-specific sequences.Type: GrantFiled: June 13, 1989Date of Patent: October 8, 1991Assignee: Salk Institute Biotechnology/Industrial Associates, Inc.Inventors: Deborah Y. Kwoh, Thomas R. Gingeras
-
Patent number: 5036013Abstract: A method is provided for converting coal to low molecular weight organic compounds comprising combining an aqueous solution of an aqueous-soluble polymeric coal substrate with a lignin peroxidase, oxygen and hydrogen peroxide. The invention is exemplified using the lignin peroxidase from Phanerochaete chrysosporium. Also provided are aqueous-soluble polymeric coal substrates suitable for lignin peroxidase-catalyzed depolymerization and methods of preparing such substrates. Finally, a method is provided for isolating the lignin peroxidase from mycelia-free, unconcentrated media of cultures of P. chrysosporium producing the enzyme.Type: GrantFiled: September 21, 1990Date of Patent: July 30, 1991Assignee: The Salk Institute Biotechnology/Industrial Associates, Inc.Inventors: Willis A. Wood, Lillian M. Wondrack
-
Patent number: 4960699Abstract: A method is provided for converting coal to low molecular weight organic compounds comprising combining an aqueous solution of an aqueous-soluble polymeric coal substrate with a lignin peroxidase, oxygen and hydrogen peroxide. The invention is exemplified using the lignin peroxidase from Phanerochaete chrysosporium. Also provided are aqueous-soluble polymeric coal substrates suitable for lignin peroxidase-catalyzed depolymerization and methods of preparing such substrates. Finally, a method is provided for isolating the lignin peroxidase from mycelia-free, unconcentrated media of cultures of P. chrysosporium producing the enzyme.Type: GrantFiled: May 9, 1988Date of Patent: October 2, 1990Assignee: Salk Institute Biotechnology/Industrial Associates, Inc.Inventors: Willis A. Wood, Lillian M. Wondrack
-
Patent number: 4960690Abstract: Nucleic acid hybridizaiton probes are provided which have sequences complementary to sequences of segments in bovine male-specific DNA and are suitable for sexing bovine embryos at the time of embryo transfer with nearly 100% accuracy.Type: GrantFiled: June 5, 1986Date of Patent: October 2, 1990Assignee: The Salk Institute Biotechnology Industrial Associates, Inc.Inventors: Steven B. Ellis, Michael M. Harpold
-
Patent number: 4939224Abstract: Novel, biologically active, 28-amino acid analogs of human vasoactive intestinal peptide are provided.Type: GrantFiled: January 21, 1988Date of Patent: July 3, 1990Assignee: The Salk Institute Biotechnology/Industrial Associates, Inc.Inventors: Gary F. Musso, Emil T. Kaiser, Gonul Velicelebi
-
Patent number: 4835252Abstract: Novel biologically active vasoactive intestinal peptide (VIP) analogues are provided.Type: GrantFiled: February 26, 1987Date of Patent: May 30, 1989Assignee: The Salk Institute Biotechnology/Industrial Associates, Inc.Inventors: Gary F. Musso, Emil T. Kaiser
-
Patent number: 4769319Abstract: Nucleic acid hybridization probes are provided which have sequences complementary to sequences of segments in bovine male-specific DNA and are suitable for sexing bovine embryos at the time of embryo transfer with virtually 100% accuracy.Type: GrantFiled: May 31, 1985Date of Patent: September 6, 1988Assignee: Salk Institute Biotechnology Industrial Associates, Inc.Inventors: Steven B. Ellis, Michael M. Harpold
-
Patent number: 4731412Abstract: Reaction of a ketoxime-derivatized resin with a strong acid salt of aspartic anhydride or glutamic anhydride yields a novel aspartyl or glutamyl ketoxime ester-derivatized resin, wherein the aspartyl or glutamyl groups are esterified predominantly at the .alpha.-carboxyl group and wherein the aspartyl or glutamyl groups are not covalently protected at the amino group or the carboxyl group that is not esterified. Aminolysis in the presence of a weak acid of the novel aspartyl or glutamyl ketoxime ester-derivatized resin, wherein the aspartyl or glutamyl groups remain as the strong acid salt, with a salt of an amino acid with a base or an amino acid ester yields the corresponding dipeptide or dipeptide ester. After aminoylsis, the ketoxime-derivatized resin can be reused. An advantageous solid-phase method is thus provided for making .alpha.-L-aspartyl dipeptide ester sweeteners, including aspartame, and the immunopotentiating dipeptide, .alpha.-L-glutamyl-L-asparagine.Type: GrantFiled: April 14, 1986Date of Patent: March 15, 1988Assignee: The Salk Institute Biotechnology/Industrial Associates, Inc.Inventors: Emil T. Kaiser, Gary F. Musso
-
Patent number: 4600532Abstract: Reaction of a ketoxime-derivatized resin with a strong acid salt of aspartic anhydride or glutamic anhydride yields a novel aspartyl or glutamyl ketoxime ester-derivatized resin, wherein the aspartyl or glutamyl groups are esterified predominantly at the .alpha.-carboxyl group and wherein the aspartyl or glutamyl groups are not covalently protected at the amino group or the carboxyl group that is not esterified. Aminolysis in the presence of a weak acid of the novel aspartyl or glutamyl ketoxime ester-derivatized resin, wherein the aspartyl or glutamyl groups remain as the strong acid salt, with a salt of an amino acid with a base or an amino acid ester yields the corresponding dipeptide or dipeptide ester. After aminolysis, the ketoxime-derivatized resin can be reused. An advantageous solid-phase method is thus provided for making .alpha.-L-aspartyl dipeptide ester sweeteners, including aspartame, and the immunopotentiating dipeptide, .alpha.-L-glutamyl-L-asparagine.Type: GrantFiled: December 28, 1984Date of Patent: July 15, 1986Assignee: The Salk Institute Biotechnology/Industrial Associates, Inc.Inventors: Emil T. Kaiser, Gary F. Musso
-
Patent number: 4593002Abstract: Foreign protein segments having specific medically or commercially useful biological functions are incorporated in surface proteins of viruses. The viruses with the incorporated protein segments are convenient agents for introducing the protein segments into animals, such as humans, and are thus useful as vaccines. Small segments of an original protein exhibiting desired functions are identified, and a DNA fragment having a nucleotide base sequence encoding that segment of the protein is isolated from an organism or synthesized chemically. The isolated DNA fragment is inserted into the DNA genome of a virus in a manner such that the inserted DNA fragment expresses itself as the foreign segment of a surface viral protein and in such a way that neither the function of the protein segment nor the function of any viral protein critical for viral replication is impaired.Type: GrantFiled: January 11, 1982Date of Patent: June 3, 1986Assignee: Salk Institute Biotechnology/Industrial Associates, Inc.Inventor: Renato Dulbecco